Department of Obstetrics and Gynecology, School of Medicine, Infertility Research Center, Shiraz University Of Medical Sciences, Shiraz, Iran.
Obstetrics and Gynecology Office, Shahid Faghihi Hospital, Zand Avenue, Shiraz, 7134844119, Iran.
BMC Womens Health. 2023 Jun 21;23(1):327. doi: 10.1186/s12905-023-02482-1.
Investigation of endometrioma size and its laterality on the quality of the embryo in patients with endometrioma compared to healthy subjects.
In this retrospective and cross-sectional study, 70 patients with unilateral and bilateral endometrioma were recruited and compared with 70 age-matched infertile patients as the control group in terms of AMH before ovum pick-up, embryo quality as well as pregnancy outcome. Additionally, in the case group, we divided both unilateral (n = 32) and bilateral endometrioma patients (n = 38) into three groups based on the size of endometrioma. (1-3 cm, 3-6 cm, 6-10 cm) RESULTS: There was no difference in terms of age, BMI, parity, and age of menarche between the case and control groups. Moreover, no significant difference was observed in the baseline level of AMH between the case 2.96 ± 2.72 ng/dl (0.21-11.3) and control 2.73 ± 2.39 (0.21-12.8) groups. (P = 0.59) There was also no significant difference concerning AMH level between unilateral 3.58 ± 3.20 ng/dl (0.21-12.8) and bilateral endometrioma 2.45 ± 2.14 (0.21 - 0.20) groups. In terms of the quality and number of embryos, there was no significant difference between the case and control groups. (P = 0.30) Although the AMH level decreased with the increase in endometrioma size, this difference was not statistically significant. (P = 0.07) There was no significant difference in terms of the embryo quality between the groups based on the size of endometrioma. (P = 0.77) In addition, no significant difference was observed between the case and control groups in the terms of birth weight and pregnancy complications, such as premature delivery, cesarean section rate, neonatal respiratory distress, jaundice, as well as hospitalization rate. Head circumference of the newborns was higher in the endometrioma group while their Apgar score was lower in the case compared to the control group.
The presence of endometrioma by itself does not affect the main result of IVF procedures, including the number and quality of embryos and pregnancy outcome. Thus, IVF and embryo preservation and even pregnancy before surgery seem to be reasonable for endometriotic patients.
研究单侧和双侧子宫内膜异位症患者的卵巢子宫内膜异位症大小及其侧别对胚胎质量的影响,并与健康受试者进行比较。
本回顾性和横断面研究共纳入 70 例单侧和双侧子宫内膜异位症患者,并将其与 70 例年龄匹配的不孕患者作为对照组,比较取卵前 AMH、胚胎质量和妊娠结局。此外,在病例组中,我们根据卵巢子宫内膜异位症的大小将单侧(n=32)和双侧卵巢子宫内膜异位症患者(n=38)分为三组。(1-3cm、3-6cm、6-10cm)
病例组和对照组在年龄、BMI、产次和初潮年龄方面无差异。此外,病例组的基础 AMH 水平也无差异,分别为 2.96±2.72ng/dl(0.21-11.3)和 2.73±2.39ng/dl(0.21-12.8)。(P=0.59)单侧 3.58±3.20ng/dl(0.21-12.8)和双侧卵巢子宫内膜异位症 2.45±2.14ng/dl(0.21-0.20)组间 AMH 水平也无显著差异。病例组和对照组在胚胎质量和数量方面无差异。(P=0.30)尽管 AMH 水平随卵巢子宫内膜异位症大小的增加而降低,但差异无统计学意义。(P=0.07)根据卵巢子宫内膜异位症的大小,胚胎质量组间无差异。(P=0.77)此外,病例组和对照组在新生儿出生体重和妊娠并发症方面,如早产、剖宫产率、新生儿呼吸窘迫、黄疸以及住院率方面无差异。卵巢子宫内膜异位症组新生儿头围较高,而病例组新生儿 Apgar 评分较低。
卵巢子宫内膜异位症本身并不影响 IVF 程序的主要结果,包括胚胎数量和质量以及妊娠结局。因此,对于子宫内膜异位症患者,IVF 和胚胎保存甚至手术前妊娠似乎是合理的。